Literature DB >> 2702115

Urolithiasis in children: current medical management.

J Laufer1, H Boichis.   

Abstract

The mechanism of stone formation in the urinary tract is reviewed. Diet, urinary tract infection and metabolic disorders account for the different epidemiological patterns of stone formation. The diagnosis and management of renal tract calculi are discussed. Calcium stones are associated with hypercalciuria, urine acidification defects, the use of furosemide in premature babies, hypercalcaemia, hyperoxaluria, hyperuricosuria, an alkaline urine and hypocitraturia. Uric acid stones occur in acid urine, from increased purine synthesis with lympho- or myeloproliferative disorders or from several inborn errors of purine metabolism which can also cause xanthine or dihydroxyadenine stones. Cystinuria, inherited as an autosomal recessive disorder is best treated with a low sodium diet, a fluid intake exceeding 40 ml/kg per day maintaining urine pH between 7.5 and 8 and, if necessary, with oral penicillamine. Oxalate stones occur in relation to diet, bowel disease and primary inherited defects in oxalate metabolism. Urinary tract infection causing struvite and carbonate apatite formation is the commonest cause of stones in Europe.

Entities:  

Mesh:

Year:  1989        PMID: 2702115     DOI: 10.1007/BF00858542

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  124 in total

1.  EFFECT OF VARIATIONS IN SODIUM INTAKE ON CALCIUM EXCRETION IN NORMAL HUMANS.

Authors:  C R KLEEMAN; J BOHANNAN; D BERNSTEIN; S LING; M H MAXWELL
Journal:  Proc Soc Exp Biol Med       Date:  1964-01

2.  Anticystinuric effects of glutamine and of dietary sodium restriction.

Authors:  P Jaeger; L Portmann; A Saunders; L E Rosenberg; S O Thier
Journal:  N Engl J Med       Date:  1986-10-30       Impact factor: 91.245

3.  Incomplete renal tubular acidosis. Physiologic studies in three patients with a defect in lowering urine pH.

Authors:  V M Buckalew; D K McCurdy; G D Ludwig; L B Chaykin; J R Elkinton
Journal:  Am J Med       Date:  1968-07       Impact factor: 4.965

4.  Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria.

Authors:  A E Broadus; K L Insogna; R Lang; A F Ellison; B E Dreyer
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

5.  Renal calcification in preterm infants: pathophysiology and long-term sequelae.

Authors:  F Ezzedeen; R D Adelman; C E Ahlfors
Journal:  J Pediatr       Date:  1988-09       Impact factor: 4.406

6.  Ultrasound and the diagnosis of renal and ureteral calculi.

Authors:  M J Diament; M Malekzadeh
Journal:  J Pediatr       Date:  1986-12       Impact factor: 4.406

7.  Is there a risk for kidney stone formation in cystic fibrosis?

Authors:  H Böhles; D Michalk
Journal:  Helv Paediatr Acta       Date:  1982-06

8.  Secondary hyperparathyroidism and bone disease in infants receiving long-term furosemide therapy.

Authors:  P S Venkataraman; B K Han; R C Tsang; C C Daugherty
Journal:  Am J Dis Child       Date:  1983-12

9.  Complete deficiency of adenine phosphoribosyltransferase: a third case presenting as renal stones in a young child.

Authors:  T M Barratt; H A Simmonds; J S Cameron; C F Potter; G A Rose; D G Arkell; D I Williams
Journal:  Arch Dis Child       Date:  1979-01       Impact factor: 3.791

10.  Tubulopathy in nephrolithiasis: consequence rather than cause.

Authors:  P Jaeger; L Portmann; J M Ginalski; A F Jacquet; E Temler; P Burckhardt
Journal:  Kidney Int       Date:  1986-02       Impact factor: 10.612

View more
  9 in total

Review 1.  Surgical aspects of urolithiasis in children.

Authors:  H el-Damanhoury; R Bürger; R Hohenfellner
Journal:  Pediatr Nephrol       Date:  1991-05       Impact factor: 3.714

2.  Consensus Definitions and Interpretation Templates for Fluoroscopic Imaging of Defecatory Pelvic Floor Disorders : Proceedings of the Consensus Meeting of the Pelvic Floor Consortium of the American Society of Colon and Rectal Surgeons, the Society of Abdominal Radiology, the International Continence Society, the American Urogynecologic Society, the International Urogynecological Association, and the Society of Gynecologic Surgeons.

Authors:  Ian Paquette; David Rosman; Gaurav Khatri; Liliana Bordeianou; Rania El Sayed; Tracy Hull; Ervin Kocjancic; Lieschen Quiroz; Susan Palmer; Abbas Shobeiri; Milena Weinstein
Journal:  Tech Coloproctol       Date:  2021-01-04       Impact factor: 3.781

3.  Urinary oxalate excretion in urolithiasis and nephrocalcinosis.

Authors:  T J Neuhaus; T Belzer; N Blau; B Hoppe; H Sidhu; E Leumann
Journal:  Arch Dis Child       Date:  2000-04       Impact factor: 3.791

4.  Renal stone disease--investigative aspects.

Authors:  M J Henderson
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

5.  Hypercalciuria is the main renal abnormality finding in Human Immunodeficiency Virus-infected children in Venezuela.

Authors:  Corina Gonzalez; G Ariceta; C B Langman; P Zibaoui; L Escalona; L F Dominguez; M A Rosas
Journal:  Eur J Pediatr       Date:  2007-06-26       Impact factor: 3.183

6.  Assessment of crystallization risk formulas in pediatric calcium stone-formers.

Authors:  Przemysław Sikora; Małgorzata Zajaczkowska; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2009-03-31       Impact factor: 3.714

7.  Idiopathic hypercalciuria associated with urinary tract infection in children.

Authors:  Vesna D Stojanović; Biljana O Milosević; Milesa B Djapić; Jelena D Bubalo
Journal:  Pediatr Nephrol       Date:  2007-06-01       Impact factor: 3.714

8.  Urinary calcium and oxalate excretion in children.

Authors:  G S Reusz; M Dobos; D Byrd; P Sallay; M Miltényi; T Tulassay
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

Review 9.  Nephrolithiasis and Nephrocalcinosis in Childhood-Risk Factor-Related Current and Future Treatment Options.

Authors:  Alexander Weigert; Bernd Hoppe
Journal:  Front Pediatr       Date:  2018-04-12       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.